Improving dermatological adverse events from amivantamab plus lazertinib: lessons from the COCOON trial.

Gillham T, Monaca F, Califano R

DOI: 10.21037/jtd-2026-0643
Published: 2026 Jun 30
Container: Journal of thoracic disease
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/jtd-2026-0643,
  title = {Improving dermatological adverse events from amivantamab plus lazertinib: lessons from the COCOON trial.},
  author = {Gillham T and Monaca F and Califano R},
  year = {2026},
  journal = {Journal of thoracic disease},
  doi = {10.21037/jtd-2026-0643},
  url = {https://doi.org/10.21037/jtd-2026-0643}
}

RIS

TY  - JOUR
TI  - Improving dermatological adverse events from amivantamab plus lazertinib: lessons from the COCOON trial.
AU  - Gillham T
AU  - Monaca F
AU  - Califano R
PY  - 2026
JO  - Journal of thoracic disease
DO  - 10.21037/jtd-2026-0643
UR  - https://doi.org/10.21037/jtd-2026-0643
ER  -

APA

T, G., F, M., & R, C. (2026). Improving dermatological adverse events from amivantamab plus lazertinib: lessons from the COCOON trial.. Journal of thoracic disease. https://doi.org/10.21037/jtd-2026-0643

Source records

pubmed · retrieved 2026-09-25T06:33:54.080Z